Completed OBSERVATIONAL NCT01660737

Observational Study With PASCALLERG ® in Patients With Hay Fever

Sponsor: Pascoe Pharmazeutische Praeparate GmbH

Conditions Hay Fever

Updated 11 times since 2017 Last updated: Mar 9, 2021 Started: Feb 29, 2012 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hay Fever and is currently completed. Pascoe Pharmazeutische Praeparate GmbH leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed

▶ Show 6 earlier versions

Apr 2021 — Dec 2022 [monthly]

Completed
Jan 2021 — Apr 2021 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pascoe Pharmazeutische Praeparate GmbH

Data source: Pascoe Pharmazeutische Praeparate GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giessen, Germany